Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 17,836 | N/A |
| Receivables | 674 | N/A |
| TOTAL | $19,112 | $N/A |
| Non-Current Assets | ||
| PPE Net | 1,983 | N/A |
| Other Non-Current Assets | 1,133 | 0 |
| TOTAL | $3,116 | $N/A |
| Total Assets | $22,228 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 2,578 | N/A |
| Accounts payable and accrued liabilities | 351 | 0 |
| Accrued Expenses | 1,853 | N/A |
| Other current liabilities | 1,431 | N/A |
| TOTAL | $9,231 | $N/A |
| Non-Current Liabilities | ||
| Long Term Debt | 4,824 | N/A |
| Deferred Revenues | 3,018 | N/A |
| Other Non-Current Liabilities | 257 | 0 |
| TOTAL | $6,719 | $N/A |
| Total Liabilities | $15,950 | $N/A |
| Shareholders' Equity | ||
| Retained earnings | -83,880 | N/A |
| Other shareholders' equity | 90,157 | 0 |
| TOTAL | $6,278 | $N/A |
| Total Liabilities And Equity | $22,228 | $0 |